Atlas Trials

Genetic Testing of Cerebrospinal Fluid to Diagnose and Monitor Glioblastoma

Clinical trial NCT05927610 · WITHDRAWN

Trial details

NCT number
NCT05927610
Sponsor
Memorial Sloan Kettering Cancer Center
Status
WITHDRAWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Glioblastoma
Start date
2023-06-19
Primary completion
2024-02-15
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.